Severely life-impairing and often lethal dementia illnesses such as Alzheimer’s disease are of the greatest medical interest. And while a cure might yet be years in the future, there are immense benefits to gain from detecting disease debut as early as possible, from both an individual and a societal perspective. In this study we explore new approaches to Alzheimer’s screening, utilizing the recent technology leaps within natural language processing and automated speech recognition. We propose a digital, mobile application based platform for psychometric data collection that can be used by patients and research participants in a non-clinical environment. In particular, we implement automated versions of two well-recognized psychometric test...
none5noAccording to the World Health Organization, the number of people suffering from dementia worl...
BACKGROUND: Modern prodromal Alzheimer's disease (AD) clinical trials might extend outreach to a gen...
BACKGROUND: Recruitment of clinical drug trials for Alzheimer's disease (AD) is a lengthy process wi...
Severely life-impairing and often lethal dementia illnesses such as Alzheimer’s disease are of the g...
Alzheimer’s is one of the most costly illnesses that exists today and the number of people with alzh...
International audienceDementia has a large economic impact on our society as cost-effective populati...
Dementia is a syndrome of illnesses resulting in cognitive decline, severely impacting the lives of ...
Due to copyright restrictions, the access to the full text of this article is only available via sub...
Abstract Background Alzheimer’s disease has become one of the most common neurodegenerative diseases...
Background: Speech impairments are an early feature of Alzheimer’s disease (AD) and consequently, an...
Alzheimer’s disease is a neurodegenerative disease that affects approximately 6% of the global popul...
Einleitung: Dementielle Erkrankungen nehmen zu und stellen Erkrankte wie Angehörige vor komplexe Her...
This study aims to investigate whether or not it is possible to use a machine learning algorithm on ...
The work presented here is part of a larger study to identify novel technologies and biomarkers for ...
Background & ObjectiveWith populations aging, the number of people with dementia worldwide is expect...
none5noAccording to the World Health Organization, the number of people suffering from dementia worl...
BACKGROUND: Modern prodromal Alzheimer's disease (AD) clinical trials might extend outreach to a gen...
BACKGROUND: Recruitment of clinical drug trials for Alzheimer's disease (AD) is a lengthy process wi...
Severely life-impairing and often lethal dementia illnesses such as Alzheimer’s disease are of the g...
Alzheimer’s is one of the most costly illnesses that exists today and the number of people with alzh...
International audienceDementia has a large economic impact on our society as cost-effective populati...
Dementia is a syndrome of illnesses resulting in cognitive decline, severely impacting the lives of ...
Due to copyright restrictions, the access to the full text of this article is only available via sub...
Abstract Background Alzheimer’s disease has become one of the most common neurodegenerative diseases...
Background: Speech impairments are an early feature of Alzheimer’s disease (AD) and consequently, an...
Alzheimer’s disease is a neurodegenerative disease that affects approximately 6% of the global popul...
Einleitung: Dementielle Erkrankungen nehmen zu und stellen Erkrankte wie Angehörige vor komplexe Her...
This study aims to investigate whether or not it is possible to use a machine learning algorithm on ...
The work presented here is part of a larger study to identify novel technologies and biomarkers for ...
Background & ObjectiveWith populations aging, the number of people with dementia worldwide is expect...
none5noAccording to the World Health Organization, the number of people suffering from dementia worl...
BACKGROUND: Modern prodromal Alzheimer's disease (AD) clinical trials might extend outreach to a gen...
BACKGROUND: Recruitment of clinical drug trials for Alzheimer's disease (AD) is a lengthy process wi...